ATE227708T1 - 1,4-disubstituierte piperdine als muskarin- antagonisten - Google Patents

1,4-disubstituierte piperdine als muskarin- antagonisten

Info

Publication number
ATE227708T1
ATE227708T1 AT97932321T AT97932321T ATE227708T1 AT E227708 T1 ATE227708 T1 AT E227708T1 AT 97932321 T AT97932321 T AT 97932321T AT 97932321 T AT97932321 T AT 97932321T AT E227708 T1 ATE227708 T1 AT E227708T1
Authority
AT
Austria
Prior art keywords
alkyl
cycloalkyl
heteroaryl
aryl
alkylheteroaryl
Prior art date
Application number
AT97932321T
Other languages
English (en)
Inventor
Theodros Asberom
Derek B Lowe
Michael J Green
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE227708T1 publication Critical patent/ATE227708T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT97932321T 1996-07-10 1997-07-08 1,4-disubstituierte piperdine als muskarin- antagonisten ATE227708T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67861896A 1996-07-10 1996-07-10
PCT/US1997/011176 WO1998001425A1 (en) 1996-07-10 1997-07-08 1,4-di-sustituted piperidines as muscarinic antagonists

Publications (1)

Publication Number Publication Date
ATE227708T1 true ATE227708T1 (de) 2002-11-15

Family

ID=24723553

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97932321T ATE227708T1 (de) 1996-07-10 1997-07-08 1,4-disubstituierte piperdine als muskarin- antagonisten

Country Status (14)

Country Link
EP (1) EP0912515B1 (de)
JP (1) JP3068206B2 (de)
KR (1) KR20000023599A (de)
AT (1) ATE227708T1 (de)
AU (1) AU728592B2 (de)
CA (1) CA2259655C (de)
DE (1) DE69717109T2 (de)
DK (1) DK0912515T3 (de)
ES (1) ES2182104T3 (de)
HU (1) HUP9904622A3 (de)
IL (1) IL127942A0 (de)
NZ (1) NZ333513A (de)
PT (1) PT912515E (de)
WO (1) WO1998001425A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1600599A (en) * 1998-02-27 1999-09-15 Warner-Lambert Company Heterocyclic substituted aniline calcium channel blockers
PL203117B1 (pl) * 1999-05-04 2009-08-31 Schering Corp Piperydynopiperydynowa pochodna użyteczna jako antagonista CCR5, zawierająca ją kompozycja farmaceutyczna i jej zastosowanie
US6635646B1 (en) 1999-05-04 2003-10-21 Schering Corporation Pegylated interferon alfa-CCR5 antagonist combination HIV therapy
US6387930B1 (en) 1999-05-04 2002-05-14 Schering Corporation Piperidine derivatives useful as CCR5 antagonists
AR033517A1 (es) 2000-04-08 2003-12-26 Astrazeneca Ab Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
AU6589801A (en) * 2000-04-28 2001-11-12 F. Hoffmann-La Roche Ag P-(sulfonyl)aryl and heteroaryls
US6640155B2 (en) 2000-08-22 2003-10-28 Lam Research Corporation Chemical mechanical polishing apparatus and methods with central control of polishing pressure applied by polishing head
DE60209736T2 (de) 2001-07-02 2006-11-02 Astrazeneca Ab Piperidinverbindungen, die sich als modulatoren der chemokinrezeptoraktivität eignen
GB0120461D0 (en) 2001-08-22 2001-10-17 Astrazeneca Ab Novel compounds
AR036366A1 (es) * 2001-08-29 2004-09-01 Schering Corp Derivados de piperidina utiles como antagonistas de ccr5, composiciones farmaceuticas, el uso de dichos derivados para la fabricación de un medicamento y un kit
GB0122503D0 (en) 2001-09-18 2001-11-07 Astrazeneca Ab Chemical compounds
PL370799A1 (en) * 2001-12-03 2005-05-30 F.Hoffmann-La Roche Ag Aminotetralin derivatives as muscarinic receptor antagonists
SE0200844D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0200843D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
KR100935615B1 (ko) * 2002-06-14 2010-01-07 토야마 케미칼 컴퍼니 리미티드 뇌기능을 개선하는 의약조성물 및 뇌기능을 개선하기 위한방법
SE0202838D0 (sv) * 2002-09-24 2002-09-24 Astrazeneca Ab Chemical compounds
GB0223223D0 (en) * 2002-10-07 2002-11-13 Novartis Ag Organic compounds
RU2224516C1 (ru) * 2002-10-17 2004-02-27 Государственное учреждение Институт токсикологии Гидрохлорид 1-фенил-1-циклопентил-4-пиперидино-2-бутин-1-ола (пентифин), обладающий м4 холиноблокирующей активностью
SE0300957D0 (sv) 2003-04-01 2003-04-01 Astrazeneca Ab Chemical compounds
EP1805142A4 (de) 2004-09-23 2009-06-10 Reddy Us Therapeutics Inc Neue pyridinverbindungen, verfahren zu ihrer herstellung und zusammensetzungen damit
CA2615650A1 (en) 2005-07-21 2007-01-25 Astrazeneca Ab Novel piperidine derivatives
BRPI0614262A2 (pt) 2005-08-02 2011-03-15 Lexicon Pharmaceuticals Inc aril piridinas e métodos para uso das mesmas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995004050A1 (en) * 1993-07-28 1995-02-09 Santen Pharmaceutical Co., Ltd. Novel 1,4-di(phenylalkyl)piperazine derivative
IL117149A0 (en) * 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists

Also Published As

Publication number Publication date
NZ333513A (en) 2000-04-28
CA2259655A1 (en) 1998-01-15
CA2259655C (en) 2003-05-13
HUP9904622A3 (en) 2001-07-30
WO1998001425A1 (en) 1998-01-15
JP3068206B2 (ja) 2000-07-24
ES2182104T3 (es) 2003-03-01
IL127942A0 (en) 1999-11-30
PT912515E (pt) 2003-03-31
DE69717109D1 (de) 2002-12-19
JPH11514671A (ja) 1999-12-14
HUP9904622A2 (hu) 2000-06-28
AU3581097A (en) 1998-02-02
EP0912515A1 (de) 1999-05-06
DK0912515T3 (da) 2003-03-10
KR20000023599A (ko) 2000-04-25
DE69717109T2 (de) 2003-04-30
AU728592B2 (en) 2001-01-11
EP0912515B1 (de) 2002-11-13

Similar Documents

Publication Publication Date Title
DE69717109D1 (de) 1,4-disubstituierte piperdine als muskarin-antagonisten
DE69733478D1 (de) Ether-muskarinantagonisten
DK1240142T3 (da) Nye modulatorer af dopaminneurotransmission
ATE224884T1 (de) Muscarin-antagonisten
EP1679069A4 (de) Neues piperidinderivat
YU8703A (sh) Derivati 4-fenil-piridina kao antagonisti receptora neurokinina-1
ATE229522T1 (de) Substituierte oximderivate anwendbar als neurokinin-antagonisten
NO990551L (no) Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister
PL314136A1 (en) Some condensed pyrrole carboxylanilides, novel class of cerebral receptor gaba ligands
RU2005114489A (ru) N-акрил-4-метиленамино-3-гидрокси-2-пиридоны в качестве противомикробных препаратов
HK1054391A1 (zh) 毒蕈碱拮抗剂
BG103984A (en) Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
ATE258170T1 (de) Benzylpiperidine und -piperazine als muscarinantagonisten
MY133108A (en) Muscarinic antagonists
ATE128463T1 (de) Piperidin und pyrrolidin derivate.
EP0309424A3 (de) Amidin-Derivate
BR0208823A (pt) Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica
CO5180624A1 (es) Antagonistas muscarinicos
DK1178047T3 (da) Diazabicyclooctanderivater og terapeutiske anvendelser deraf
RU2003105827A (ru) Средства против слабоумия, содержащие производные 2-арил-8-оксодигидропурина, в качестве активного ингредиента
ECSP003505A (es) Derivados de 4-fenil- pirimidina
TH32619A (th) อนุพันธ์ พิเพอริดิน

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0912515

Country of ref document: EP

REN Ceased due to non-payment of the annual fee